DEF CON 32 - 3DU Homo ex Machina - Lacey Harbour

AI is transforming medical device development by enabling personalized, point-of-care solutions, but the industry faces significant security and regulatory challenges, especially in decentralized manufacturing models. 2:15

Key Takeaways:
• The future of medical devices will be personalized, AI-driven, and produced at the point of care through "medical device production systems" (MDPS), shifting from traditional manufacturing to integrated hospital-based production 4:00.
• MDPS integrates design, manufacturing, and clinical feedback within a hospital environment, blurring the lines between device makers and health delivery organizations 8:30.
• AI will enable automatic segmentation, design generation, surgical technique labeling, and demand planning—particularly in orthopedics with 3D-printed implants 19:20.
• Medical device manufacturers are not HIPAA-covered entities, creating critical data security and access risks when interacting with EMRs and patient data 15:50.

The industry is entering a pivotal phase requiring urgent, collaborative efforts to ensure safety, security, and patient consent in AI-driven, decentralized medical device production.

Sources:

• 2:15 Discussion on AI’s impact on healthcare and the need for new care standards.
• 4:00 Introduction to the medical device production system (MDPS) as a shift in manufacturing model.
• 8:30 Breakdown of MDPS workflow and its integration into hospital care ecosystems.
• 19:20 Overview of AI applications